Stellaromics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
321 Harrison Ave Fl 6, Boston, Massachus...Phone Number
(857) 675-9157Website
www.stellaromics.comRevenue
$9.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Stellaromics
Founded in Boston, Stellaromics is transforming biomedical research through its proprietary technology that reveals complex three-dimensional transcription and translation patterns within native biological tissue. At the core of this innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), the company's flagship product. STARmap enables researchers to visualize gene expression within intact tissue, aiding in the identification of treatment targets and advancing biomedical discovery.Explore more
Stellaromics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stellaromics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Stellaromics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Stellaromics
Check if Stellaromics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Stellaromics launches new products
Funding: Get notified immidiatlly once Stellaromics has new funding data
Click to see if Stellaromics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Stellaromics recently announced quarterly report
Stellaromics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Stellaromics
Compare insights from companies similar to Stellaromics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stellaromics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Stellaromics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Stellaromics.
Stellaromics financials insights
Gather financial insights about Stellaromics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$25M
2025
Series B
$80M
Stellaromics Tech Stack
A closer look at the technologies used by Stellaromics
Most Recent Scoops
Hiring Plans
Stellaromics has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Project
, according to a mid-level source in content & experience, is in the midst of initiatives related to social media marketing. The organization is currently evaluating various vendors.
Social Media, Social Media Marketing
Project
, according to a mid-level source in content & experience, has completed initiatives related to community and reviews within the last twelve months.
Customer Marketing, Relationship Marketing, Marketing Relationships
Project
Analytics & Insights, Data Management, Data Science, Marketing Analytics / Insights
Stellaromics News & Media
Stellaromics Launches Pyxa™ at AGBT, the First Commercial Platform for 3D Spatial Multi-Omics in Intact Tissue
BOSTON, Feb. 19, 2026 /PRNewswire/ -- Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a fundamental shift in spatial biology — from 2D thin-section...Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors
Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON, Feb. 10, 2026 /PRNewswire/ -- Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors....Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
Dr. Hailing Shi to apply 3D spatial multi-omics to decode RNA regulation in the human brain and neurodegenerative diseases BOSTON, Jan. 28, 2026 /PRNewswire/ -- Stellaromics, a pioneer in high-resolution 3D spatial biology, today announced the installation of its Pyxa™ 3D spatial...Stellaromics Establishes First U.S. Pyxa™ 3D Spatial Transcriptomics Site at UC Irvine
Renowned vision researcher Dr. Rui Chen to apply 3D spatial multi-omics for mapping sensory systems and advancing Human Cell Atlas discoveries BOSTON, Dec. 3, 2025 /PRNewswire/ -- Stellaromics, a pioneer in 3D spatial biology, today announced the installation of its first U.S.-based Pyxa™...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stellaromics
Sign Up For FreeTo access detailed company insights
Founded in Boston, Stellaromics is transforming biomedical research through its proprietary technology that reveals complex three-dimensional transcription and translation patterns within native biological tissue. At the core of this innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), the company's flagship product. STAR... Read More
